SCHEMBL19953891

SCHEMBL19953891

c1ccc(N(c2ccccc2)c2ccc(-c3ccc(-c4nnc(-c5ccc(-c6ccc(N(c7ccccc7)c7ccccc7)cc6)cc5)o4)cc3)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 14/20 0.61
RAB9A P51151 14/20 0.61
SMN1; SMN2 Q16637 5/20 0.61
HPGD P15428 5/20 0.58
KDM4E B2RXH2 4/20 0.58
ALDH1A1 P00352 4/20 0.58
MAPT P10636 2/20 0.58
HSD17B10 Q99714 2/20 0.58
GLA P06280 1/20 0.58
ALOX15 P16050 1/20 0.58
KMT2A Q03164 2/20 0.55
POLB P06746 1/20 0.55
NFKB1 P19838 1/20 0.55
NFKB2 Q00653 1/20 0.55
RELA Q04206 1/20 0.55
MEN1 O00255 1/20 0.55
ATAD2 Q6PL18 1/20 0.52
GAA P10253 1/20 0.51
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14466533 0.98 NPC1 (0.65) NPC1RAB9ASMN1; SMN2HPGDKDM4E
SCHEMBL14465411 0.98 NPC1 (0.65) NPC1RAB9ASMN1; SMN2HPGDKDM4E
SCHEMBL14465492 0.98 NPC1 (0.65) NPC1RAB9ASMN1; SMN2HPGDKDM4E
SCHEMBL14465525 0.98 NPC1 (0.65) NPC1RAB9ASMN1; SMN2HPGDKDM4E
SCHEMBL14466552 0.98 NPC1 (0.65) NPC1RAB9ASMN1; SMN2HPGDKDM4E
SCHEMBL14465408 0.98 NPC1 (0.65) NPC1RAB9ASMN1; SMN2HPGDKDM4E
SCHEMBL502473 0.98 NPC1 (0.64) NPC1RAB9ASMN1; SMN2HPGDKDM4E
SCHEMBL14018360 0.98 NPC1 (0.64) NPC1RAB9ASMN1; SMN2HPGDKDM4E
SCHEMBL9680820 0.98 NPC1 (0.64) NPC1RAB9ASMN1; SMN2HPGDKDM4E
SCHEMBL14579892 0.96 NPC1 (0.68) NPC1RAB9ASMN1; SMN2HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3755695-B1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO LTD (KR) 2023-10-11 EP disclosed
EP-4250899-A2 ORGANIC ELECTROLUMINESCENT DEVICE Samsung Display Co., Ltd. (KR) 2023-09-27 EP disclosed
EP-3639308-B1 ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG DISPLAY CO LTD (KR) 2023-07-26 EP disclosed
EP-3809479-B1 ORGANIC ELECTROLUMINESCENT DEVICE EMITTING BLUE LIGHT SAMSUNG DISPLAY CO LTD (KR) 2023-07-12 EP disclosed
WO-2022257817-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY APPARATUS 清华大学 2022-12-15 WO disclosed
US-11165035-B2 Organic electroluminescent device emitting blue light CYNORA GMBH (DE) 2021-11-02 US disclosed
EP-3809479-A1 ORGANIC ELECTROLUMINESCENT DEVICE EMITTING BLUE LIGHT cynora GmbH (DE) 2021-04-21 EP disclosed
WO-2019164383-A1 COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREOF 한국생산기술연구원 2019-08-29 WO disclosed
US-20190177303-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-06-13 US disclosed
US-9917270-B1 Organic electroluminescent device having an exciton quenching layer CYNORA GMBH (DE) 2018-03-13 US disclosed
US-9917270-B1 Organic electroluminescent device having an exciton quenching layer CYNORA GMBH (DE) 2018-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190177303-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, ORC3, OR51E2 NPC1 3654/4885RAB9A 3768/4885SMN1; SMN2 4734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.